Amgen Files NDA, Seeks FDA Approval For Parathyroid Drug By: TalkMarkets August 25, 2015 at 20:49 PM EDT Amgen shares end the day down 1% after filing an NDA for its intravenous drug etelcalcetide. Read More >> Related Stocks: Amgen